Skip to main content

STIFEL FINANCIAL CORP

Position in AQST — Aquestive Therapeutics, Inc.

CIK 720672 ST. LOUIS, MO

Position in AQST

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,505,516
+$11,919 QoQ
Shares Held
361,903
+0.6% QoQ
Ownership
0.288%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 184 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 94% Shared 0% None 6%

Common Shares in AQST Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

STIFEL FINANCIAL CORP holds $141,737,028 across 29 Drug Manufacturers - Specialty & Generic names. AQST ranks #16 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AQST

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,505,516 361,903
2026-03-31 $1,493,597 359,903
2025-12-31 $2,388,442 369,728
2025-09-30 $2,048,331 366,428
2025-06-30 $1,238,694 374,228
2025-03-31 $1,087,870 375,128
2024-12-31 $1,418,876 398,561
2024-09-30 $477,800 95,944
2024-06-30 $1,033,453 397,482
2024-03-31 $1,660,897 389,882